StockData
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. (ACHV) stock

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $691.50MP/E –Yield –

Achieve Life Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Achieve Life Sciences

Achieve Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Achieve Life Sciences figures

See a number that looks wrong?